QUSVM
Qiming U.S. Ventures Management Portfolio holdings
AUM
$55.6M
1-Year Est. Return
98.09%
1 Year Est. Return
+98.09%
AUM
$55.6M
AUM Growth
+$32M
(+136%)
Holding
6
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRML
1
DELISTED
Tourmaline Bio
TRML
| $35.5M | 63.76% |
741,691
|
|
||
2
Korro Bio
KRRO
$66.1M
| $17.6M | 31.68% |
368,085
|
|
||
3
Jasper Therapeutics
JSPR
$47.9M
| $2.21M | 3.97% |
928,964
|
|
||
4
Kezar Life Sciences
KZR
$45.8M
| $323K | 0.58% |
82,871
|
|
||
|
HLVX
5
DELISTED
HilleVax
HLVX
| – | – |
-372,615
|
|
||
6
Ventyx Biosciences
VTYX
$622M
| – | – |
-412,225
|
|